Evidence map›Paper›PMID 33952318›Full record

ArticleTrials2021

Effect of intensive care unit-specific virtual reality (ICU-VR) to improve psychological well-being and quality of life in COVID-19 ICU survivors: a study protocol for a multicentre, randomized controlled trial.

Johan H Vlake, Jasper Van Bommel, Evert-Jan Wils, Tim I M Korevaar, Merel E Hellemons, Anna F C Schut, Joost A M Labout, Lois L H Schreuder, Diederik Gommers, Michel E Van Genderen

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04925765 (Virtual Reality Biofeedback for Postpartum Anxiety and Depression), which is not on this map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04925765 nacompletednot on this map

Virtual Reality Biofeedback for Postpartum Anxiety and Depression

TypeinterventionalSponsorGrace Lim, MD, MSRan2021 to 2021Enrolled6ConditionsAnxiety and Depression, Postpartum Depression, Pregnancy RelatedArmsVirtual Reality Biofeedback Session
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Non-Pharmacological Therapies for Post-Viral Syndromes, Including Long COVID: A Systematic Review.International journal of environmental research and public health · 2023
    Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Johan H VlakeDepartment of Intensive Care, Erasmus MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-0532-0252
Jasper Van BommelDepartment of Intensive Care, Erasmus MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Evert-Jan WilsDepartment of Intensive Care, Franciscus Gasthuis & Vlietland, Kleiweg 500, 3045 PM, Rotterdam, The Netherlands.
Tim I M KorevaarDepartment of Internal Medicine, Academic Centre for Thyroid Diseases, Erasmus MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Merel E HellemonsDepartment of Pulmonology, Erasmus MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Anna F C SchutDepartment of Intensive Care, Ikazia Hospital, Montessoriweg 1, 3083 AN, Rotterdam, The Netherlands.
Joost A M LaboutDepartment of Intensive Care, Maasstad Hospital, Maasstadweg 21, 3079 DZ, Rotterdam, The Netherlands.
Lois L H SchreuderDepartment of Intensive Care, Erasmus MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Diederik GommersDepartment of Intensive Care, Erasmus MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Michel E Van GenderenDepartment of Intensive Care, Erasmus MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. M.vanGenderen@erasmusmc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe SARS-CoV-2 outbreak has resulted in a tremendous increase in hospital and intensive care unit (ICU) admissions all over the world. Patients with severe coronavirus disease 2019 (COVID-19) warranting ICU treatment usually have prolonged mechanical ventilation and are expected to be prone to develop psychological impairments, such as post-traumatic stress disorder (PTSD), anxiety and depression, which negatively impact quality of life. To date, no effective treatment strategy is available. In the current trial, we aim to assess the effect of an ICU-specific virtual reality (ICU-VR) intervention on psychological well-being and quality of life after COVID-19 ICU treatment.

methodsIn this multicentre, randomized controlled trial, we aim to examine whether COVID-19-specific ICU-VR, offered 3 months after hospital discharge, improves psychological well-being and quality of life. Secondary objectives are, firstly, to examine the intra-group changes in psychological well-being and quality of life and the inter-group differences in psychological well-being and quality of life during follow-up, up to 12 months after hospital discharge, and secondly, to examine patients' satisfaction with and rating of ICU care and aftercare and patients' perspectives on ICU-VR. Eighty adult patients treated for COVID-19 in the mixed-surgical ICUs of four hospitals in Rotterdam, the Netherlands, will be included and randomized (1:1) to either early or late ICU-VR between June 29 and December 31, 2020. Patients randomized to early ICU-VR will receive the ICU-VR intervention during an outpatient clinic visit 3 months after hospital discharge, whereas patients randomized to late ICU-VR will receive ICU-VR 6 months after hospital discharge. Primary outcomes of this study are psychological well-being, assessed using the Impact of Event Scale-Revised (IES-R) and the Hospital Anxiety and Depression Scale (HADS), and quality of life, assessed using the European Quality of Life 5 Dimensions (EQ-5D) and RAND-36 questionnaires, up to 6 months after hospital discharge. DISCUSSION: Currently, an effective treatment for psychological sequelae after ICU treatment for specific illnesses is unavailable. Results from this study will provide insight whether virtual reality is a modality that can be used in ICU aftercare to improve psychological well-being and quality of life, or satisfaction, after ICU treatment for specific illnesses such as COVID-19.

trial registrationThis trial has been retrospectively registered on the Netherlands Trial Register on August 14, 2020 ( NL8835 ).

Indexed as

COVID-19Virtual RealityAdultHumansIntensive Care UnitsMulticenter Studies as TopicNetherlandsQuality of LifeRandomized Controlled Trials as TopicSARS-CoV-2SurvivorsAnxietyCoronavirus disease 2019 (COVID-19)DepressionHealth-related quality of life (HRQoL)Post-intensive care syndrome (PICS)Post-traumatic stress disorder (PTSD)Randomized controlled trialSARS-CoV-2Virtual reality

Identifiers

PMID33952318
PMCPMC8097671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.